CD40LG and COVID-19: The study reported that 68.2% and 70.1% of COVID-19 patients were successfully diagnosed with the rN protein-based IgM and IgG ELISAs respectively, and 77.1% and 74.3% were diagnosed using the rS protein-based IgM and IgG ELISAs.